Conclusion
In combination with TGCM, the new Evita-open-NEO HP can easily and safely be implanted with minimal blood loss.
Conflict of Interest: Heinz Jakob is consultant to JOTEC/CryoLife, former inventor and recipient of royalties until 2019; Klaus Görlinger is the medical director of Tem Innovations GmbH, Munich, Germany